Zaloguj się

Gotowe bibliografie tematyczne / Medical Biotechnology / Artykuły w czasopismach

Artykuły w czasopismach na temat „Medical Biotechnology”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Medical Biotechnology.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 30 lipca 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Medical Biotechnology”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Yaseen, Arshed H., Halah M. H. Al-Hasani i Umer Abdullah Ahmed Alelyan. "Biotechnology for medical diagnosis". Drug and Pharmaceutical Science Archives 02, nr 01 (2022): 01–05. http://dx.doi.org/10.47587/dpsa.2022.2101.

Pełny tekst źródła

Streszczenie:

Biotechnology is broadly defined as, “using organisms or their products for commercial purposes” encompasses a wide range. Since the beginning of time, people have used (traditional) biotechnology. Wheat, brew alcohol, and breed food crops and domestic animals have all been made using this grain. Molecular biology’s most recent breakthroughs, on the other hand, have given new life to biotechnology’s relevance and potential. Biotechnology has become a hot topic among the general public. There’s a good chance that modern biotechnology will have a big impact on the environment. Small-molecule (chemical) medications produced by well-known pharmaceutical companies have traditionally accounted for the vast majority of human illness treatments. The current article discussed.

Style APA, Harvard, Vancouver, ISO itp.

2

Pillai, D. R. "Medical Biotechnology". Clinical Infectious Diseases 59, nr 8 (27.06.2014): 1201–2. http://dx.doi.org/10.1093/cid/ciu510.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

de Lange, Catherine. "Insider: Medical biotechnology". New Scientist 206, nr 2754 (marzec 2010): 44–45. http://dx.doi.org/10.1016/s0262-4079(10)60809-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Sáenz, Tirso W. "Biotechnology for Medical Applications". Science, Technology and Society 10, nr 2 (wrzesień 2005): 225–48. http://dx.doi.org/10.1177/097172180501000203.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Ivanov, I. "Pharmaceutical and Medical Biotechnology". Biotechnology & Biotechnological Equipment 21, nr 1 (styczeń 2007): 74–79. http://dx.doi.org/10.1080/13102818.2007.10817418.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Fontanarosa, Phil B., i Catherine D. DeAngelis. "Medical Applications of Biotechnology". JAMA 291, nr 8 (25.02.2004): 1003. http://dx.doi.org/10.1001/jama.291.8.1003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Fontanarosa, Phil B. "Medical Applications of Biotechnology". JAMA 293, nr 7 (16.02.2005): 866. http://dx.doi.org/10.1001/jama.293.7.866.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Verjan García, Noel. "Biotechnology, powerful tools for research and development". Orinoquia 13, nr 1 (1.01.2009): 2. http://dx.doi.org/10.22579/20112629.217.

Pełny tekst źródła

Streszczenie:

ABSTRACT: The concept of biotechnology has been in the human mind since very ancient times, when the first human beings discovered the production of wine by fermenting fruit juices, the brewing beer industry, and the conversion of milk into cheese or yogurt. However, as these basic processes have going through a wide range of developments to supply specific requirements, biotechnology has evolved and some of its most dramatic advances were observed during in the last 30-years. Modern biotechnology begins with the ability to transfer a specific gene from one organism to another by using a set of genetic engineering techniques, thus recombinant DNA technology sparked an era o biotech revolution. This major achievement, together with the maintenance and growth of genetically uniform plant-and animal cell cultures increased dramatically the spectrum of biotechnology’s applications in disease prevention, treatment and quality of life.

Style APA, Harvard, Vancouver, ISO itp.

9

Guryev, Evgenii L., Samah Shanwar, Andrei Vasilevich Zvyagin, Sergey M. Deyev i Irina V. Balalaeva. "Photoluminescent Nanomaterials for Medical Biotechnology". Acta Naturae 13, nr 2 (27.07.2021): 16–31. http://dx.doi.org/10.32607/actanaturae.11180.

Pełny tekst źródła

Streszczenie:

Creation of various photoluminescent nanomaterials has significantly expanded the arsenal of approaches used in modern biomedicine. Their unique photophysical properties can significantly improve the sensitivity and specificity of diagnostic methods, increase therapy effectiveness, and make a theranostic approach to treatment possible through the application of nanoparticle conjugates with functional macromolecules. The most widely used nanomaterials to date are semiconductor quantum dots; gold nanoclusters; carbon dots; nanodiamonds; semiconductor porous silicon; and up-conversion nanoparticles. This paper considers the promising groups of photoluminescent nanomaterials that can be used in medical biotechnology: in particular, for devising agents for optical diagnostic methods, sensorics, and various types of therapy.

Style APA, Harvard, Vancouver, ISO itp.

10

Yakovlev, A. Yu, A. A. Kruglikova i S. I. Chernysh. "Calliphoridae Flies in Medical Biotechnology". Entomological Review 99, nr 3 (czerwiec 2019): 292–301. http://dx.doi.org/10.1134/s0013873819030023.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Molochaeva, L. G., i N. M. Mirzoeva. "Biotechnology and advanced medical technologies". BIO Web of Conferences 82 (2024): 02038. http://dx.doi.org/10.1051/bioconf/20248202038.

Pełny tekst źródła

Streszczenie:

This study considers a complex synergy of biotechnologies and advanced medical technologies. The growing convergence of their positions is clearly shown in shaping the transformational era in healthcare. The study exposes developments ranging from precision gene editing to organ bioprinting and the rise of personalized medicine through extensive literature reviews, case study analyses, and expert interviews. Notwithstanding that these advancements promise unprecedented therapeutic and diagnostic capabilities, they also present challenges. Technological barriers in association with profound ethical problems, e.g., the implications of gene editing on future generations and issues of equity in healthcare, emphasize the complexity of this union. The article emphasizes the potential of this integration in the development of proactive health paradigms, stressing the significance of judicious utilization, continued dialogue, and ethical stewardship. The results show the following: although the fusion of biotechnologies and medical technologies holds great promise, it requires a prudent approach to research and application.

Style APA, Harvard, Vancouver, ISO itp.

12

Zamora-González, Edgar Oswaldo, Angel Herráez, Paula Daniela Gutiérrez-Muñoz, Olivia Torres-Bugarín, María Valentina Toral-Murillo, Benjamín Gómez-Díaz, Cecilia Adriana Calderón-Reyes i in. "Implementation of Biotechnology Applied to Medicine Course Using Virtual Laboratories: Perceptions and Attitudes of Students". Education Sciences 14, nr 2 (2.02.2024): 157. http://dx.doi.org/10.3390/educsci14020157.

Pełny tekst źródła

Streszczenie:

The rapid evolution of biotechnology across various sectors, including agriculture, industry, and medicine, has profoundly transformed our comprehension of the world. Virtual laboratories (VLs) provide an immersive learning experience that can enhance future generations’ understanding of biotechnology’s medical applications. This study investigated the impact of incorporating VLs into a short course on biotechnology applied to medicine on the attitudes and perceptions of third-year medical students (n = 210). A validated questionnaire was employed to assess their perspectives, attitudes, and experience with virtual laboratory platforms before and after the course. The findings revealed a significant positive change in 7/38 questionnaire items (p < 0.05), indicating that the VL experience modified perceptions about biotechnology. This study emphasizes the importance of exploring innovative teaching methods for biotechnology and highlights the advantages of VL in educating future physicians. The primary concerns of the students were the misuse of personal genetic information and biotechnological applications involving animal modification. Overall, the students had a favorable experience using the virtual laboratory platforms. These findings collectively suggest that VL can positively influence perceptions and attitudes toward biotechnology among healthcare professionals.

Style APA, Harvard, Vancouver, ISO itp.

13

Klyuchko, O. M. "INFORMATION COMPUTER TECHNOLOGIES FOR USING IN BIOTECHNOLOGY: ELECTRONIC MEDICAL INFORMATION SYSTEMS". Biotechnologia Acta 11, nr 3 (czerwiec 2018): 5–6. http://dx.doi.org/10.15407/biotech11.03.005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Pereginya, O. V. ,. "TRANSLATION MEDICINE, BIOMEDICINE AND MEDICAL BIOTECHNOLOGY: THE TRANSITION TO PERSONALIZED MEDICINE". Biotechnologia Acta 13, nr 2 (kwiecień 2020): 5–11. http://dx.doi.org/10.15407/biotech13.02.005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Aparna, R., K. V. Leela i S. R. Manjula. "Medical Biotechnology – Application and future prospects". Indian Journal of Medical Microbiology 39 (wrzesień 2021): S76. http://dx.doi.org/10.1016/j.ijmmb.2021.08.262.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

ISHINE, Noriyuki. "Medical Applications of Low Temperature Biotechnology". Proceedings of thermal engineering conference 2002 (2002): 373–75. http://dx.doi.org/10.1299/jsmeptec.2002.0_373.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Chang, Thomas Ming Swi. "Artificial Cell Biotechnology for Medical Applications". Blood Purification 18, nr 2 (2000): 91–96. http://dx.doi.org/10.1159/000014430.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Evens, Ronald P., i Mark Witcher. "Biotechnology". Therapeutic Drug Monitoring 15, nr 6 (grudzień 1993): 514–20. http://dx.doi.org/10.1097/00007691-199312000-00011.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Dundar, Munis, Satya Prakash, Ratnesh Lal i Donald K. Martin. "Future Biotechnology". EuroBiotech Journal 3, nr 2 (1.04.2019): 53–56. http://dx.doi.org/10.2478/ebtj-2019-0006.

Pełny tekst źródła

Streszczenie:

Abstract The field of biotechnology is large and could be considered tritely as simply the development of technology that is based on biology. It is clear that the concepts of biotechnology can spread to cover many different fields of application and so the future developments in biotechnology will be similarly wide-ranging across many fields of applications. Here we focus onto medical biotechnology and further refine our discussion onto considering aspects of genetics and nanotechnologies that could impact on the development of future biotechnologies in the medical field. These areas that we consider in this brief article provide the basis for a panel discussion on Future Biotechnology at the European Biotechnology Congress held in Valencia, Spain in April 2019.

Style APA, Harvard, Vancouver, ISO itp.

20

Mizan, Shaikh. "Medical Biotechnology: Problems and Prospects in Bangladesh". Journal of Enam Medical College 3, nr 1 (20.02.2013): 32–46. http://dx.doi.org/10.3329/jemc.v3i1.13873.

Pełny tekst źródła

Streszczenie:

Biotechnology is the knowledge and techniques of developing and using biological systems for deriving special products and services. The age-old technology took a new turn with the advent of recombinant DNA techniques, and boosted by the development of other molecular biological techniques, cell culture techniques and bioinformatics. Medical biotechnology is the major thrust area of biotechnology. It has brought revolutions in medicine quick methods for diagnosing diseases, generation of new drugs and vaccines, completely novel approach of treatment are only a few to mention. The industrial and financial bulk of the industry mushroomed very rapidly in the last three decades, led by the USA and western advanced nations. Asian countries like China, India, South Korea, Taiwan and Singapore joined late, but advancing forward in a big way. In all the Asian countries governments supported the initiatives of the expert and entrepreneur community, and invested heavily in its development. Bangladesh has got great potential in developing biotechnology and reaping its fruits. However, lack of commitment and patriotism, and too much corruption and irresponsibility in political and bureaucratic establishment are the major hindrance to the development of biotechnology in Bangladesh. DOI: http://dx.doi.org/10.3329/jemc.v3i1.13873 J Enam Med Col 2013; 3(1): 32-46

Style APA, Harvard, Vancouver, ISO itp.

21

Adrio, Jose L., i Arnold L. Demain. "Fungal biotechnology". International Microbiology 6, nr 3 (1.09.2003): 191–99. http://dx.doi.org/10.1007/s10123-003-0133-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

NOSSAL, G. J. V. "THE BIOTECHNOLOGY REVOLUTION AND AUSTRALIAN MEDICAL SCIENCE*". Australian and New Zealand Journal of Medicine 17, nr 1 (luty 1987): 98–103. http://dx.doi.org/10.1111/j.1445-5994.1987.tb05067.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Atkinson, Simon. "Product developments in biotechnology and medical applications". Membrane Technology 2003, nr 2 (luty 2003): 10–11. http://dx.doi.org/10.1016/s0958-2118(03)02019-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Vequist, David G., i Erika Valdez. "The correlation between medical tourism and biotechnology". Journal of Commercial Biotechnology 15, nr 4 (październik 2009): 287–89. http://dx.doi.org/10.1057/jcb.2009.24.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Bell, Jennifer. "Medical Writing explores the many faces of biotechnology". Medical Writing 32, nr 4 (11.12.2023): 2–4. http://dx.doi.org/10.56012/zskr5275.

Pełny tekst źródła

Streszczenie:

This Medical Writing issue focuses on the crucial role of medical writing and communications in biotechnology and product development in healthcare. In the pharmaceutical and medical device industries, biotechnology uses biological systems and living organisms in R&D and production processes for product development. Some biotechnologies include biologic and biosimilar pharmaceuticals, vaccines, and advanced therapy medicinal products, including gene and cell therapies and tissue engineered products.

Style APA, Harvard, Vancouver, ISO itp.

26

Bush, Peggy. "Overview of Biotechnology". Journal of Pharmacy Practice 11, nr 1 (luty 1998): 6–12. http://dx.doi.org/10.1177/089719009801100103.

Pełny tekst źródła

Streszczenie:

Modern biotechnology has advanced rapidly in the past few decades, driven largely by scientific advances which have led to the development of techniques such as recombinant DNA and hybridoma technology. The United States is a leader in the growing biotechnology field. Biotechnology has wide potential application in diverse areas including health care, chemicals, food, and waste treatment. Health care represents the largest sector in the biotechnology industry with hundreds of products in development including therapeutics, vaccines, diagnostics, devices and drug delivery systems. Unique legal, regulatory, and societal issues associated with biotechnology-derived products are being addressed as the field continues to evolve.

Style APA, Harvard, Vancouver, ISO itp.

27

Evens, Ronald P. "The Biotechnology Industry". Journal of Pharmacy Practice 11, nr 1 (luty 1998): 13–18. http://dx.doi.org/10.1177/089719009801100104.

Pełny tekst źródła

Streszczenie:

Growth and change are the hallmarks of the developing biotechnology industry. Since the first approval of a biological product in 1982, over 40 biologicals, many of them medical breakthroughs, have been brought to market. The majority of biotechnology companies focus on developing human therapeutic agents, but about 25 percent of biotechnology companies focus on the diagnostic area, using monoclonal antibody technology, polymerase chain reaction (PCR) technology, and genetics to provide advances in diagnosis and disease monitoring. Structurally, few biotechnology firms are fully integrated companies with full capabilities in research, development, manufacturing, and sales and marketing. Many pursue strategic alliances with other companies to enhance their capabilities in research, development, and sales and marketing. Research alliances between companies and universities are also frequently used to enhance research capabilities. As the industry has matured, consolidation has occurred, with major pharmaceutical companies purchasing biotechnology companies and biotechnology companies merging to expand their capabilities. Research investment, as a percentage of gross sales, continues to be very high for biotechnology companies compared with traditional pharmaceutical companies. The cost of drug development is high, but the probability of approval appears to be somewhat better in the biotechnology field compared with traditional pharmaceuticals. Today, the biotechnology product pipeline is rich, with between 400 to 700 products in various stages of clinical development. Technology developments beyond recombinant DNA technology and monoclonal antibodies, such as antisense, genomics, and combinatorial chemistry, will lead to additional therapeutic and diagnostic breakthroughs.

Style APA, Harvard, Vancouver, ISO itp.

28

Chen, Jiawen. "The Advancement of Medical Biotechnology in Developing Countries: Economic Opportunities and Challenges". Highlights in Business, Economics and Management 23 (29.12.2023): 395–400. http://dx.doi.org/10.54097/45c92q28.

Pełny tekst źródła

Streszczenie:

Starting from decades ago, medical biotechnology has revolutionized the healthcare industry by offering new hopes for previously untreatable diseases and improving overall health outcomes. To explore the advancements in medical biotechnology, this research essay begins by introducing several examples of medical biotechnologies that are currently in progress of advancement, including CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), Recombinant DNA technology, and Stem Cell Research. Then, it delves into the developments of medical biotechnology in developing countries and examines the opportunities and challenges faced during its progress. The medical biotechnology industry in most developing countries is relatively immature, so new opportunities appear as improving health outcomes and driving economic growth. Nevertheless, the development and adoption of medical biotechnology in developing countries are under different levels of financial burdens, so supports and collaborations on research and development from the healthcare leaders are essential. Finally, this research essay offers some suggestions to the cost reduction strategies of medical biotechnology in developing countries by promoting the hypothetical combination of value-based healthcare and modern monetary theory.

Style APA, Harvard, Vancouver, ISO itp.

29

Bauer, Martin W. "Controversial medical and agri-food biotechnology: a cultivation analysis". Public Understanding of Science 11, nr 2 (kwiecień 2002): 93–111. http://dx.doi.org/10.1088/0963-6625/11/2/301.

Pełny tekst źródła

Streszczenie:

Whether biotechnology is one or several developments is not clear. Once distinctions are required, the question is: Which one prevails? When the good, the bad, and the ugly settle, where do they fall? Evaluation implies distinction, and representation drives attitude. The controversies over biotechnology are fertile ground on which to study these issues. The imports of genetically modified (GM) soya into Europe in 1996-97 and the cloning of Dolly the sheep from adult cells in 1997 changed the symbolic environment for genetic engineering. The ensuing public controversies came to focus mainly on field trials of GM crops and food labeling. This paper will explore the relationship between quality press coverage and public perception, in particular the cultivation of the contrast between “desirable” biomedical (RED) and “undesirable” agri-food (GREEN) biotechnology in Britain. The argument draws on a systematic analysis of the British press coverage of biotechnology from 1973 to 1999 and analysis of public perceptions in 1996 and 1999. The paper concludes that the debate over GM crops and food ingredients fostered the RED-GREEN contrast among the newspaper-reading public, thereby shielding RED biotechnology from public controversy, and ushered in a realignment of the regulatory framework in 2000.

Style APA, Harvard, Vancouver, ISO itp.

30

Patel, Alok, Ulrika Rova, Paul Christakopoulos i Leonidas Matsakas. "From Yeast to Biotechnology". Bioengineering 9, nr 12 (2.12.2022): 751. http://dx.doi.org/10.3390/bioengineering9120751.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Smith, Charles G. "Biotechnology and Therapeutics". Clinical Pharmacology and Therapeutics 53, nr 1 (styczeń 1993): 96. http://dx.doi.org/10.1038/clpt.1993.15.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Iseki, Hiroshi. "Medical device based on cutting edge nano-biotechnology". Drug Delivery System 26, nr 1 (2011): 37–45. http://dx.doi.org/10.2745/dds.26.37.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Wordsworth, R. "Medical - Biotechnology. How to live when nobody dies." Engineering & Technology 15, nr 4 (1.05.2020): 74–77. http://dx.doi.org/10.1049/et.2020.0425.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Lambert, Claude. "Flow Cytometry, a Unique Biotechnology in Medical Applications". Journal of Clinical Medicine 11, nr 20 (20.10.2022): 6198. http://dx.doi.org/10.3390/jcm11206198.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Luparev, E. B., i E. V. Epifanova. "Futurism of medical biotechnology and administrative legal personality". Law Gazette of the Kuban State University, nr 4 (2021): 82–88. http://dx.doi.org/10.31429/20785836-13-4-82-88.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Persson, Anders. "Research ethics and the development of medical biotechnology". Xenotransplantation 13, nr 6 (listopad 2006): 511–13. http://dx.doi.org/10.1111/j.1399-3089.2006.00352_5.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

Walles, Thorsten. "Tracheobronchial bio-engineering: Biotechnology fulfilling unmet medical needs". Advanced Drug Delivery Reviews 63, nr 4-5 (kwiecień 2011): 367–74. http://dx.doi.org/10.1016/j.addr.2011.01.011.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Mattanovich, Diethard, i Vassily Hatzimanikatis. "Editorial: Metabolic modeling in biotechnology and medical research". Biotechnology Journal 8, nr 9 (wrzesień 2013): 962–63. http://dx.doi.org/10.1002/biot.201300378.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Rani, Madhu, Sweeti, Spikey, Preeti Kaushik, Deepak i Anjela Gahalayan. "Stem Cell and its Applications in Medical Biotechnology". UTTAR PRADESH JOURNAL OF ZOOLOGY 45, nr 8 (8.04.2024): 143–57. http://dx.doi.org/10.56557/upjoz/2024/v45i84008.

Pełny tekst źródła

Streszczenie:

Stem cells are undifferentiated cells in multicellular organisms that can be specialized into many types of cells and multiply into different types of cells. Stem cells can be produced from many sources in the body such as early embryos, embryonic tissue, foetal membranes i e; chorion and amnion, umbilical cord, and amniotic fluid. Stem cells are also present in organs of adult organisms like blood, skin, skeletal muscle, bone marrow, etc., Stem cells can be totipotent, pluripotent, multipotent, and unipotent. Stem cells are used to regenerate injured cells in the body, and repair the cells due to any kind of disease. From all types of cells, totipotent stem cells can generate any kind of cells in the body so they are the most important type of cells. Along with this, pluripotent stem cells also produce all types of cells, except the placenta or embryonic cells. These cells can be isolated from the body from the late embryonic stage after 1 week of the birth of a child, from the miscarriage of 12 weeks, and also from the umbilical cord of the child. These can be stored for another 2 decades. Another type is multipotent stem cells, which can generate a limited number of cells in a specific type; the last fourth type is unipotent stem cells, which can only produce cells of their own type. Diagnosis with stem cells is a useful technique to treat patients with many blood-related diseases for example blood cancer, thalassemia, etc., It also cures diseases like diabetes, liver disease, bone and cartilage, and organ transplantation.

Style APA, Harvard, Vancouver, ISO itp.

40

Chen, Shao-Yen, Yih-Ru Chu, Chen-Yung Lin i Tzen-Yuh Chiang. "Students' knowledge of, and attitudes towards biotechnology revisited, 1995-2014: Changes in agriculture biotechnology but not in medical biotechnology". Biochemistry and Molecular Biology Education 44, nr 5 (18.05.2016): 475–91. http://dx.doi.org/10.1002/bmb.20969.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Tami, Joseph A. "The Science of Biotechnology". Journal of Pharmacy Practice 11, nr 1 (luty 1998): 19–27. http://dx.doi.org/10.1177/089719009801100105.

Pełny tekst źródła

Streszczenie:

The quest to understand how genetic information is passed from one generation to the next reached a major milestone in the 1950s with the discovery of the complementary double-helix structure of DNA by Watson and Crick and the demonstration by Kornberg that DNA was capable of self-replication. These breakthroughs provided the stimulus for a flurry of research that culminated in a basic understanding of the genetic code and a statement of the central dogma of molecular biology: DNA goes to RNA goes to protein. In expressing a gene, RNA is formed from the DNA template in a process called transcription. The process of RNA forming protein is known as translation. During translation, amino acids are linked to form protein. The primary structure of proteins is thus determined by the sequence of amino acids. Using x-ray crystallography and computer imaging, it has been possible to determine the three-dimensional structure of many proteins and to design small molecule peptides which can either mimic or block the function of the protein and thus be useful therapeutic agents.

Style APA, Harvard, Vancouver, ISO itp.

42

Tami, Joseph A. "Major Techniques of Biotechnology". Journal of Pharmacy Practice 11, nr 1 (luty 1998): 28–37. http://dx.doi.org/10.1177/089719009801100106.

Pełny tekst źródła

Streszczenie:

Since the discovery of the structure and function of DNA over 40 years ago, the established knowledge of molecular biology has increased dramatically, and many new tools have been discovered and utilized by scientists to develop new therapeutic agents. Important tools that are used in recombinant DNA technology include restriction endonucleases (cleave DNA), DNA ligase (link DNA molecules together), and cloning vectors (place foreign DNA into an organism such as bacterial or yeast cells in order to mass produce the protein encoded by that foreign DNA). The development of hybridoma technology provided a method to produce virtually unlimited quantities of pure antibody with a single specificity. These immuno-globulins are known as monoclonal antibodies, and have provided both therapeutic and diagnostic agents. Antisense molecules are oligonucleotides which bind to the messenger RNA (mRNA) of a target gene and selectively inhibit the production of specific proteins. Potential applications for these molecules include cancer and viral and inflammatory diseases. The more recent development of the polymerase chain reaction (PCR) has provided a tool that has revolutionized diagnostic testing in diverse areas such as infectious diseases, genetic abnormalities, and cancer.

Style APA, Harvard, Vancouver, ISO itp.

43

Fish, Douglas N. "Biotechnology and Safety Assessment". Annals of Pharmacotherapy 29, nr 4 (kwiecień 1995): 435. http://dx.doi.org/10.1177/106002809502900422.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Tami, Joseph, i Ronald P. Evens. "Evaluation of Biotechnology Products". Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 16, nr 4 (8.07.1996): 527–36. http://dx.doi.org/10.1002/j.1875-9114.1996.tb03635.x.

Pełny tekst źródła

Streszczenie:

Biotechnology products have had a substantial impact on the health care system, including cost and patient care. In some hospitals, agents produced by biotechnology account for 10% or more of the pharmacy budget. As of May 1996, 29 biological products had been approved for use in the United States, including, in many instances, agents for diseases or conditions for which no drugs were previously available. These compounds are different molecules, often with very different types of properties from synthetic chemicals. They are relatively expensive compared with traditionally manufactured synthetic drugs. The increasing availability, individual characteristics, and relative expense of these products mandate a systematic method of evaluating them for use in various health care systems. Thirteen essential points must be considered when evaluating them for clinical use: availability of alternative agents; indications (both labeled and unlabeled); glycosylation; adverse events; administration and pharmacokinetics; monitoring needs; shipping, handling, and storage; stability; pharmacoeconomic studies; concomitant drug costs; special pharmacy procedures; reimbursement; and manufacturer's support.

Style APA, Harvard, Vancouver, ISO itp.

45

Bush, Peggy. "Pharmacotherapeutics of Biotechnology-Derived Products". Journal of Pharmacy Practice 11, nr 1 (luty 1998): 54–71. http://dx.doi.org/10.1177/089719009801100109.

Pełny tekst źródła

Streszczenie:

Biotechnology has contributed to important advances in the healthcare field. Products include various hormones, enzymes, cytokines, vaccines, and monoclonal antibodies, with use in diverse therapeutic areas. The majority of approved biotechnology-derived therapeutic products are recombinant proteins. Many have orphan drug status and, therefore, are used in relatively small patient populations. Newer generation biotechnology products are likely to include small molecules, gene therapy products, and increased numbers of vaccines and monoclonal antibody products. Biotechnology provides the means to develop diverse, innovative, and effective approaches to the prevention, treatment, and cure of human disease.

Style APA, Harvard, Vancouver, ISO itp.

46

Hargreaves, Lucy. "The evolution of biotechnology: From ancient civilisations to modern day". Medical Writing 32, nr 4 (11.12.2023): 40–44. http://dx.doi.org/10.56012/gxcw4769.

Pełny tekst źródła

Streszczenie:

This article takes you on an intriguing exploration of the intertwined histories of biotechnology and medical writing. From ancestral plant cultivation to revolutionary advancements in genomics, proteomics, and bioinformatics, we delve into the profound evolution and influence of biotechnology on humanity. We also shine a spotlight on the critical role of medical writers, who meticulously document, interpret, and communicate these scientific breakthroughs to wider audiences. This article offers a key to understanding the convergence of science and communication, highlighting the incredible journey of biotechnology and medical writing.

Style APA, Harvard, Vancouver, ISO itp.

47

Kahan, Jonathan S., i Jeffrey N. Gibbs. "Food and drug administration regulation of medical device biotechnology, and food and food additive biotechnology". Applied Biochemistry and Biotechnology 11, nr 6 (grudzień 1985): 507–16. http://dx.doi.org/10.1007/bf02798644.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Mohd Meerah, Tamby Subahan, Mohd Fairuz Ahmad Harail i Lilia Halim. "MALAYSIAN SECONDARY SCHOOL STUDENTS’ KNOWLEDGE AND ATTITUDES TOWARDS BIOTECHNOLOGY". Journal of Baltic Science Education 11, nr 2 (20.06.2012): 153–63. http://dx.doi.org/10.33225/jbse/12.11.153.

Pełny tekst źródła

Streszczenie:

The purpose of this research is to investigate secondary students’ knowledge and attitude towards biotechnology and its application. A questionnaire was administered to 214 (16 years old) students who are either taking Biology or General Science. The questionnaire contained 15 items measuring students’ knowledge and also 28 items measuring students’ attitude towards biotechnology. The students’ level of knowledge is high but limited only to medical issues. Students showed positive attitude towards biotechnology applications that are related to medical and economic purposes. However, students are unaware of ethical issues related to biotechnology applications. The t-test showed that there was no significant difference of students’ knowledge of biotechnology in terms of gender. However, there was a significant difference in terms of students’ attitude towards biotechnology between Biology and General Science students. These findings serve as initial input of Malaysian secondary students’ knowledge and attitudes towards biotechnology and its application. Key words: attitude, biotechnology, knowledge, secondary school, survey.

Style APA, Harvard, Vancouver, ISO itp.

49

Ranade, Vasant V. "Biotechnology: Pharmaceutical Aspects". American Journal of Therapeutics 17, nr 1 (styczeń 2010): 121. http://dx.doi.org/10.1097/mjt.0b013e31817c947a.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Jameel, S. "Ethics in biotechnology and biosecurity". Indian Journal of Medical Microbiology 29, nr 4 (2011): 331. http://dx.doi.org/10.4103/0255-0857.90155.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!